Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Netto, Joao Prola
Neuwelt, Edward A.
Funding for this research was provided by:
Walter S. and Lucienne Driskill Foundation
National Institutes of Health (NS044687, CA137488-15S1)